Top compounds associated with response to CLDN14


Feature Type Standardized
Nominal ANOVA
mRNA TPCA-1 GDSC1000 pan-cancer AAC -0.11 0.0001
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.11 0.0001
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.12 0.0002
mRNA BX-912 GDSC1000 pan-cancer AAC -0.11 0.0004
mRNA Axitinib CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA PI-103 GDSC1000 pan-cancer AAC -0.11 0.0004
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.099 0.0007
mRNA AR-42 GDSC1000 pan-cancer AAC -0.1 0.0007
mRNA CAY10603 GDSC1000 pan-cancer AAC -0.1 0.0008
mRNA PHA-793887 GDSC1000 pan-cancer AAC -0.094 0.0009
Download CSV